BioXcel Therapeutics, Inc. (BTAI)
NASDAQ: BTAI · IEX Real-Time Price · USD
1.170
-0.070 (-5.65%)
At close: Jul 19, 2024, 4:00 PM
1.180
+0.010 (0.85%)
Pre-market: Jul 22, 2024, 7:17 AM EDT
BioXcel Therapeutics Market Cap
BioXcel Therapeutics has a market cap or net worth of $43.91 million as of July 22, 2024. Its market cap has decreased by -86.16% in one year.
Market Cap
43.91M
Enterprise Value
71.75M
1-Year Change
-86.16%
Ranking
Category
Stock Price
$1.17
Market Cap Chart
Since March 8, 2018, BioXcel Therapeutics's market cap has decreased from $167.60M to $43.91M, a decrease of -73.80%. That is a compound annual growth rate of -18.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 43.90M | -49.19% |
| Dec 29, 2023 | 86.40M | -85.65% |
| Dec 30, 2022 | 601.90M | 5.82% |
| Dec 31, 2021 | 568.80M | -49.48% |
| Dec 31, 2020 | 1.13B | 327.25% |
| Dec 31, 2019 | 263.50M | 336.26% |
| Dec 31, 2018 | 60.40M | -63.96% |
| Mar 8, 2018 | 167.60M | - |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Matinas BioPharma Holdings | 44.97M |
| Lucid Diagnostics | 44.71M |
| Regencell Bioscience Holdings | 44.50M |
| CalciMedica | 44.40M |
| Qilian International Holding Group | 44.26M |
| Envoy Medical | 43.90M |
| Fortress Biotech | 43.89M |
| Lexaria Bioscience | 43.16M |